MedWatch

Genmab CEO on legal fight with Janssen: Standing up straight and fighting for what's morally and ethically right

The trial between collaborative partners Genmab and Janssen is moving along, but according to Jan van de Winkel it's too early to conclude when a verdict will be made.

Photo: Mik Eskestad/ERH

Genmab and its CEO Jan van de Winkel will fight to the last breath in in its current dispute with US partner Janssen. At least, that is the impression you get from speaking to the Dutch bussinessman.

"Sometimes in life you just need to stand up straight and fight for what you believe is morally and ethically right. This is what we are doing here. We are a very ethical company, and I believe that we have the right to defend ourselves," says van de Winkel.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs